IRCCS Istituto Europeo di Oncologia s.r.l. (IEO)

Milan, Lombardy 20141

0 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Transitional Cell

Studies at this site

• Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma — Completed